PNC FINANCIAL SERVICES GROUP, INC. - VIRPAX PHARMACEUTICALS INC ownership

VIRPAX PHARMACEUTICALS INC's ticker is VRPX and the CUSIP is 928251107. A total of 17 filers reported holding VIRPAX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of VIRPAX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$80,700
-25.9%
100,8750.0%0.00%
Q2 2023$108,945
+37.6%
100,8750.0%0.00%
Q1 2023$79,187
+26.2%
100,8750.0%0.00%
Q4 2022$62,744
-47.7%
100,8750.0%0.00%
Q3 2022$120,000
-29.0%
100,8750.0%0.00%
Q2 2022$169,000
+201.8%
100,875
+301.5%
0.00%
Q1 2022$56,000
-34.9%
25,1250.0%0.00%
Q4 2021$86,00025,1250.00%
Other shareholders
VIRPAX PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 701,455$550,6420.48%
Quantum Private Wealth, LLC 10,000$7,8500.00%
Warberg Asset Management LLC 17,012$13,3540.00%
Belpointe Asset Management LLC 19,045$14,9500.00%
OSAIC HOLDINGS, INC. 600$4710.00%
PNC FINANCIAL SERVICES GROUP, INC. 100,875$79,1870.00%
WELLS FARGO & COMPANY/MN 60$470.00%
NORTHERN TRUST CORP 15,221$11,9480.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 66,038$51,6080.00%
View complete list of VIRPAX PHARMACEUTICALS INC shareholders